Ocain Tim 4
4 · ENANTA PHARMACEUTICALS INC · Filed Dec 4, 2018
Insider Transaction Report
Form 4
Ocain Tim
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2018-12-03$32.27/sh+2,000$64,540→ 8,127 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1]2018-12-03−2,000→ 58,000 totalExercise: $32.27Exp: 2024-01-30→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]100% of the shares subject to this option are fully vested and exercisable.
Signature
/s/ Nathaniel S. Gardiner as attorney in fact|2018-12-04